ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 786 filers reported holding ISHARES TR in Q3 2020. The put-call ratio across all filers is 1.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,219,191 | -7.5% | 1,417,967 | -4.0% | 0.22% | -5.1% |
| Q2 2023 | $189,430,795 | +7.9% | 1,477,201 | +9.9% | 0.24% | -3.7% |
| Q1 2023 | $175,573,129 | +367.2% | 1,344,496 | +395.5% | 0.25% | +324.1% |
| Q4 2022 | $37,575,986 | -100.0% | 271,356 | -62.7% | 0.06% | -61.1% |
| Q3 2022 | $92,838,404,000 | -20.3% | 726,640 | -21.3% | 0.15% | -17.7% |
| Q2 2022 | $116,441,937,000 | -31.7% | 922,778 | -24.8% | 0.18% | -21.0% |
| Q1 2022 | $170,447,515,000 | -12.9% | 1,226,936 | -4.3% | 0.23% | -17.9% |
| Q4 2021 | $195,701,574,000 | -38.2% | 1,282,280 | -34.5% | 0.28% | -37.9% |
| Q3 2021 | $316,613,255,000 | +7.2% | 1,958,271 | +8.5% | 0.45% | +14.8% |
| Q2 2021 | $295,376,794,000 | +25.5% | 1,804,930 | +15.4% | 0.39% | +13.7% |
| Q1 2021 | $235,387,612,000 | +2512.1% | 1,563,414 | +3771.9% | 0.34% | +2050.0% |
| Q4 2020 | $9,011,383,000 | -97.6% | 40,378 | -98.5% | 0.02% | -97.1% |
| Q3 2020 | $381,866,356,000 | -2.2% | 2,778,495 | -2.1% | 0.55% | -20.6% |
| Q2 2020 | $390,387,597,000 | +257.1% | 2,836,900 | +187.3% | 0.69% | +207.1% |
| Q1 2020 | $109,333,798,000 | +5.0% | 987,568 | +51.4% | 0.22% | +17.9% |
| Q4 2019 | $104,110,156,000 | -53.9% | 652,152 | -68.3% | 0.19% | -52.7% |
| Q3 2019 | $226,076,438,000 | +35.2% | 2,060,364 | +68.1% | 0.40% | +20.7% |
| Q2 2019 | $167,237,208,000 | +51.5% | 1,225,683 | +60.2% | 0.33% | +39.9% |
| Q1 2019 | $110,393,780,000 | +44.2% | 765,266 | +50.7% | 0.24% | +31.5% |
| Q4 2018 | $76,548,738,000 | -71.6% | 507,915 | -73.8% | 0.18% | -54.5% |
| Q3 2018 | $269,510,569,000 | +23.7% | 1,938,237 | +13.2% | 0.40% | +9.6% |
| Q2 2018 | $217,960,523,000 | +16.5% | 1,712,754 | -2.3% | 0.36% | +3.7% |
| Q1 2018 | $187,168,377,000 | -20.2% | 1,753,498 | -20.2% | 0.35% | -15.9% |
| Q4 2017 | $234,572,409,000 | +28.8% | 2,196,988 | +309.9% | 0.42% | -6.5% |
| Q3 2017 | $182,130,078,000 | +9.4% | 535,961 | +1.1% | 0.44% | -11.4% |
| Q2 2017 | $166,517,898,000 | -32.6% | 529,926 | -36.4% | 0.50% | -23.0% |
| Q1 2017 | $247,023,742,000 | +249.8% | 833,052 | +192.1% | 0.65% | +97.0% |
| Q4 2016 | $70,610,012,000 | -68.9% | 285,225 | -68.9% | 0.33% | -64.6% |
| Q3 2016 | $227,052,686,000 | -34.0% | 918,199 | -32.7% | 0.94% | -39.8% |
| Q2 2016 | $344,079,461,000 | +61.9% | 1,364,430 | +58.8% | 1.55% | +72.6% |
| Q1 2016 | $212,491,152,000 | -76.4% | 859,187 | -67.8% | 0.90% | -59.0% |
| Q4 2015 | $901,995,165,000 | +99.7% | 2,666,025 | +79.1% | 2.19% | +93.6% |
| Q3 2015 | $451,584,645,000 | -21.1% | 1,488,753 | -4.0% | 1.13% | -29.1% |
| Q2 2015 | $572,204,937,000 | -2.2% | 1,550,820 | -9.0% | 1.60% | -1.5% |
| Q1 2015 | $585,357,866,000 | +45800.2% | 1,704,451 | +40443.6% | 1.62% | +32300.0% |
| Q4 2014 | $1,275,284,000 | -40.6% | 4,204 | -46.1% | 0.01% | +150.0% |
| Q3 2014 | $2,146,130,000 | +14.5% | 7,797 | +6.9% | 0.00% | 0.0% |
| Q2 2014 | $1,874,520,000 | +109.9% | 7,293 | +208.6% | 0.00% | – |
| Q1 2014 | $892,956,000 | – | 2,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |